ContractWarrant Agreement • October 9th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledOctober 9th, 2002 Company Industry JurisdictionTHIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR EXEMPTION FROM REGISTRATION UNDER THE FOREGOING LAWS.
CONVERTIBLE SECURED NOTE PURCHASE AGREEMENTConvertible Secured Note Purchase Agreement • October 9th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledOctober 9th, 2002 Company Industry JurisdictionTHIS AGREEMENT (this "Agreement") is made as of October 4, 2002, by and among ALLIANCE PHARMACEUTICAL CORP., a New York corporation (the "Company") and the Holders signatory hereto (each a "Holder" and, collectively, the "Holders").
WITNESSETHDebenture General Collateral Security Agreement • October 9th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledOctober 9th, 2002 Company Industry Jurisdiction
GENERAL COLLATERAL SECURITY AGREEMENTGeneral Collateral Security Agreement • October 9th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledOctober 9th, 2002 Company Industry JurisdictionGENERAL COLLATERAL SECURITY AGREEMENT dated as of October 4, 2002, made by Alliance Pharmaceutical Corp., a New York corporation (the "Grantor"), to ___________________, as Collateral Agent (the "Collateral Agent") for the benefit of the holders of the Notes (as hereinafter defined)(collectively, the "Secured Parties").
IMAGENT SECURITY AGREEMENTSecurity Agreement • October 9th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledOctober 9th, 2002 Company Industry JurisdictionIMAGENT SECURITY AGREEMENT dated as of October 4, 2002, made by Alliance Pharmaceutical Corp., a New York corporation (the "Grantor"), to ____________ __________, as Collateral Agent (the "Collateral Agent") for the benefit of the holders of the Notes (as hereinafter defined) (collectively, the "Secured Parties").
IMAGENT AND OXYGENT PATENT AND TRADEMARK SECURITY AGREEMENTPatent and Trademark Security Agreement • October 9th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledOctober 9th, 2002 Company Industry JurisdictionIMAGENT AND OXYGENT PATENT AND TRADEMARK SECURITY AGREEMENT dated as of October 4, 2002, made by Alliance Pharmaceutical Corp., a New York corporation (the "Grantor"), to ____________ __________, as Collateral Agent (the "Collateral Agent") for the benefit of the holders of the Notes (as hereinafter defined) (collectively, the "Secured Parties").
WITNESSETHPatent and Trademark Security Agreement • October 9th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledOctober 9th, 2002 Company Industry Jurisdiction
WITNESSETHDebenture Agent Security Agreement • October 9th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledOctober 9th, 2002 Company Industry Jurisdiction